Cardiovascular disease is an emerging medical issue in patients with hemophilia (PWH)
and its prevalence is increasing up to 15% in PWH in the United States. Atrial fibrillation …

Patients with lower extremity peripheral artery disease (PAD) are at increased risk of major
adverse limb events (MALE). The efficacy and safety of direct oral anticoagulants (DOACs) …

Anticoagulant and antiplatelet drugs effectively prevent thrombotic events in patients with
cardiovascular diseases, ischemic stroke, peripheral vascular diseases, and other …

Background This pairwise meta-analysis determines the difference in bleeding risks
associated with the use of novel oral anticoagulants (NOACs) and aspirin. Methods …

Background/Aims: The incidence of acute gastrointestinal bleeding (GIB) increases with the
utilization of anticoagulant and nonsteroidal anti-inflammatory drugs (NSAIDs). This study …

Background Patients with non-valvular atrial fibrillation (NVAF) need prophylactically
antithrombotic therapies to reduce the risk of stroke. We hypothesized that the prognostic …

Prescribing anticoagulation therapy in very old (≥ 80-years) patients with atrial fibrillation
(AF) is an emerging clinical issue, but current knowledge and recommendations are …

目的分析非瓣膜性心房颤动(NVAF) 患者抗凝治疗现状, 探讨未抗凝治疗的影响因素.
方法通过医院信息系统选取2021 年1—12 月徐州医科大学附属宿迁医院心血管内科收治的 …

During the last decade, the term embolic stroke of undetermined source (ESUS) was
introduced in a pursue to standardized diagnostic workup in a more targeted sub-population …

BACKGROUND: Very elderly patients (≥ 85 years old) with non-valvular atrial fibrillation
(NVAF) have an increased risk of both stroke and bleeding. We aimed to determine the …